Seebri Neohaler and Alcohol/Food Interactions
There are 2 alcohol/food/lifestyle interactions with Seebri Neohaler (glycopyrrolate).
Glycopyrrolate Alcohol (Ethanol)
Moderate Drug Interaction
Ask your doctor before using glycopyrrolate together with ethanol (alcohol). Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while you are taking glycopyrrolate. You should be warned not to exceed recommended dosages and to avoid activities requiring mental alertness. If your doctor prescribes these medications together, you may need a dose adjustment to safely take this combination. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Switch to professional interaction data
Glycopyrrolate High Blood Pressure (Hypertension)
Minor Potential Hazard, Moderate plausibility
anticholinergics - hypertension
Cardiovascular effects of anticholinergics may exacerbate hypertension. Therapy with anticholinergic agents should be administered cautiously in patients with hypertension.
Switch to professional interaction data
Seebri Neohaler drug interactions
There are 203 drug interactions with Seebri Neohaler (glycopyrrolate).
Seebri Neohaler disease interactions
There are 15 disease interactions with Seebri Neohaler (glycopyrrolate) which include:
- arrhythmias
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- tardive dyskinesia
- infectious diarrhea
- myasthenia gravis
- ulcerative colitis
- psychoses
- Down's syndrome
- liver impairment
- renal impairment
- hypertension
- fever
Report options
More about Seebri Neohaler (glycopyrrolate)
- Seebri Neohaler consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anticholinergic bronchodilators
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Symbicort
Symbicort (budesonide and formoterol) is used to prevent bronchospasm in people with asthma or ...
Ventolin HFA
Ventolin HFA (albuterol) is used to treat or prevent breathing problems in patients who have asthma ...
Breztri Aerosphere
Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler used for the ...
Ventolin
Ventolin is used for asthma, acute, asthma, maintenance, bronchiectasis, bronchospasm prophylaxis ...
Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is used to prevent airflow obstruction or bronchospasm in ...
Spiriva
Spiriva (tiotropium) is used to prevent bronchospasm in people with bronchitis, emphysema, or COPD ...
Anoro Ellipta
Anoro (umeclidinium and vilanterol inhalation powder) is used to treat chronic obstructive ...
Xopenex
Xopenex is a short-acting bronchodilator used to treat or prevent bronchospasm in asthma and other ...
Stiolto Respimat
Stiolto Respimat (tiotropium bromide and olodaterol) is used to treat COPD. Includes Stiolto ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.